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Abstract: We generated a knock-in mouse line in which the gene encoding brain-derived neurotrophic
factor (Bdnf ) was replaced with a sequence for proBDNF containing human single nucleotide
polymorphisms encoding arginines proximal to the cleavage site (R125M and R127L). The ratio of the
mature form of BDNF (mBDNF) to precursor BDNF (proBDNF) in hippocampal tissue lysates was
decreased in a manner dependent on the number of copies of the mutant gene, indicating that the
mutations inhibited proteolytic conversion of proBDNF into mBDNF. Although homozygous mice
had a proBDNF/mBDNF ratio of ~9:1, they survived until adulthood. The levels of mBDNF were
reduced by 57% in heterozygous mutant mice, which exhibited a depressive-like behavior in the tail
suspension test and weight gain when housed in social isolation, showing that impaired proBDNF
cleavage contributes to stress-induced depressive-like phenotypes. Furthermore, socially isolated
heterozygous mice displayed a pronounced deficit in daily nest-building behaviors. These findings
suggest that the decreased production of mBDNF by impaired proBDNF cleavage disturbs daily
activities in mice.
Keywords: BDNF; depression; nest building; cleavage; SNP; social isolation
1. Introduction
Brain-derived neurotrophic factor (BDNF; mBDNF—mature form of BDNF) promotes the
survival of developing peripheral neurons [1,2] and has trophic effects on a variety of neuronal
types [3]. mBDNF is highly expressed in many brain regions in response to neuronal activity [4,5] and
facilitates activity-dependent synaptic plasticity via tropomyosin-related kinase B (TrkB) receptors [6].
Brain function and activity-dependent secretion of mBDNF are disrupted in individuals expressing a
common variant of mBDNF with a single nucleotide polymorphism (SNP) (reference SNP cluster ID
rs6265), resulting in the replacement of the valine at residue 66 in the pro-peptide region with methionine
(Val66Met) [7]. Recent reports suggest that impaired mBDNF signaling contributes to depression and
that antidepressants can restore mBDNF expression [8–10]. Moreover, postmortem brain samples
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from depressed patients have reduced amounts of mBDNF and of the TrkB receptor [11–14], and TrkB
phosphorylation is reduced in suicide victims [15].
Various rodent models have been used to explore the role of mBDNF in depression. Male mice
with reduced levels of BDNF in forebrain regions exhibit depressive-like behavior [16], and knockdown
of BDNF in the dentate gyrus area of the hippocampus in rats produces depressive-like effects [17].
However, depressive-like behaviors were not reported for mice overexpressing a nonfunctional TrkB
receptor in the forebrain [18,19] or for mice lacking one Bdnf allele (BDNF+/− mice) [18,20,21], although
these mice were slower to escape in the learned helplessness paradigm of depression [20]. It is
also indicated that depressive-like behaviors are induced by exposure to stress, which results in
reduced levels of mBDNF in the cortex and hippocampus in animal models [22–24]. In addition,
Mishima et al. reported that mice deficient for Ca2+-dependent activator protein for secretion 2 (CAPS2),
a regulator of dense-core vesicle exocytosis that is involved in the secretion of mBDNF and NT-3,
display depressive-like behaviors after chronic treatment with corticosterone [25].
BDNF transcription through its multiple promoters, its trafficking, and its secretion have all
been implicated in the onset and development of depression [26]. mBDNF, like other neurotrophins,
is synthetized as a precursor protein (proBDNF; molecular mass of ~32 kDa) that is proteolytically
processed into mature BDNF (mBDNF; molecular mass of ~14 kDa) by intracellular and/or
extracellular proteases, most prominently by the proprotein convertase PC7, but also extracellularly by
metalloproteinases and plasmin (reviewed by Lessmann [4]). Several reports demonstrate that proBDNF
promotes cell death, growth cone retraction, dendritic spine shrinkage, and long-term depression,
whereas mBDNF promotes neuronal survival, spine protrusion, and long-term potentiation [27–29].
In addition to a common BDNF polymorphism, V66M (rs6265) [7], we explored the molecular
roles of rare tandem SNPs at nucleotides 373 (G/T) and 379 (G/T) (rs1048220 and rs1048221, respectively)
in the coding region of the human BDNF gene [29]. Notably, these SNPs are located near the cleavage
site of proBDNF (Figure 1a) and code for a methionine in place of arginine at position 125 (R125M) and
leucine at position 127 (R127L), respectively (Figure 1a). In our previous report, a bioinformatic analysis
predicted that these variations undergo disordered-to-ordered transitions around the cleavage site of
proBDNF [29]. In in vitro studies, the proteolytic conversion of the mutant proBDNF construct into
mBDNF was impaired and induced shrinkage of dendritic spines in cultured hippocampal neurons [29].
As a reduction in mBDNF is associated with depression, as described above, impairment of proBDNF
cleavage may represent a mechanism by which these and similar SNPs influence the development of
psychiatric phenotypes in mice.
In the present study, we generated a knock-in mouse line in which the endogenous Bdnf allele
was replaced with cDNA encoding human BDNF, in which two arginine residues located proximal
to the cleavage site are mutated (Figure 1a). These mutations markedly impaired the conversion of
proBDNF into mBDNF, demonstrating that these arginine residues are crucial for proBDNF cleavage
in vivo. Heterozygous knock-in mice, which produce approximately 50% less mBDNF than wild-type
littermates, exhibited a pronounced depressive-like behavior and impaired nest building when housed
for eight weeks under conditions of social isolation. These findings suggest that proteolytic cleavage of
proBDNF plays pathophysiological roles in the daily activities of mice and the susceptibility to mood
disorders, such as depression-like behaviors.
2. Results
2.1. Generation of a Knock-in Mouse Line with Impaired Conversion of proBDNF into mBDNF
We generated a knock-in mouse line using the homologous recombination strategy described
previously [30]. Specifically, the endogenous Bdnf allele was replaced with a sequence encoding
proBDNF containing rare human tandem SNPs, at nucleotides 373 (G/T) and 379 (G/T), which change
two arginines (amino acids 125 and 127) proximal to the cleavage site to methionine and leucine,
respectively, near the cleavage site of proBDNF (Figure 1a, top). We previously reported that these
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mutations result in inefficient conversion of proBDNF to mBDNF in cultured neurons [29]. In the
present article, homozygous and heterozygous knock-in mice are referred to as BDNFpro/pro and
BDNFpro/+, respectively.
BDNF proteins are highly expressed in hippocampus [31], and Rauskolb et al. (2010) [32]
determined the ratio of mBDNF to proBDNF in hippocampal tissues of 9-week-old mice by
immunoprecipitation followed by Western blotting (IP-WB). We used this method to first analyze
how efficiently proBDNF was converted into mBDNF in the hippocampi of 9-week-old BDNF+/+,
BDNF+/pro, and BDNFpro/pro littermate mice. We used a mouse monoclonal antibody (clone; mAb#9)
recognizing both proBDNF and mature BDNF for IP [32] and a mouse anti-pan-BDNF antibody (clone;
EPR1292; Abcam) for the WB. Consistent with the findings of Rauskolb et al. (2010) [32], mBDNF
expression was much higher than that of proBDNF in control mice (Figure 1b, BDNF+/+). Notably, the
ratio of mBDNF to proBDNF appears to decrease in a manner dependent on the number of copies of
the mutant gene, indicating the amino acid substitution of the first and second arginines proximal to
the cleavage site to methionine and leucine (see Figure 1a, top; R→M and R→ L) inhibits proteolytic
conversion of proBDNF into mBDNF in vivo, as was observed in vitro [29]. Although nonspecific
bands with higher and lower molecular masses were also seen, the findings were confirmed by
including positive and negative controls with hippocampal lysates from 10-day-old wild-type (BDNF
KO+/+) and BDNF-null (BDNF KO−/−) mice. Neither mBDNF nor proBDNF bands were detected
in BDNF KO−/− lysates (Figure 1b, BDNF KO−/−). While mBDNF was abundant in the lysates of
BDNF KO+/+ mice (Figure 1b, BDNF KO+/+, mBDNF), proBDNF was not detectable, probably because
the BDNF levels are not high in the developing mouse [32]. Furthermore, we loaded recombinant
(rec.) mBDNF and proBDNF generated in E. coli (Figure 1b). As the E. coli-derived proBDNF is not
glycosylated [33], the corresponding band had a lower molecular mass than that for proBDNF in
mouse lysates. On the basis of these findings, we reason that the two rare human SNPs proximal to the
cleavage site of proBDNF cause inefficient cleavage, resulting in decreased levels of mBDNF in the
hippocampus in vivo in a manner dependent on mutant gene dosage.
Further, to investigate the ratio of mBDNF and proBDNF, we performed Western blot analysis of the
hippocampal lysates prepared from 9-week-old BDNF+/+, BDNF+/pro, and BDNFpro/pro littermate mice.
To detect the immunoreactive signals of mBDNF and proBDNF, we used a monoclonal anti-pan-BDNF
antibody (clone; 3C11, Icosagen) as reported by Wosnitzka et al. (2020) because they showed that
mBDNF and proBDNF were detected in Western blot analysis using antibody 3C11 in HEK293 cell
lysate transfected with BDNF or BDNF-GFP fusion, while their respective signals were not seen in
a Western blot of the lysates prepared from the cerebral cortex of Bdnf−/− animals [34]. In line with
the result of Figure 1b, the ratio of mBDNF to proBDNF decreased in a manner dependent on the
number of copies of the mutant gene (Figure 1c, arrows). The bands corresponding to mBDNF and
proBDNF were not clearly seen in the lanes loaded with the lysates prepared from the cerebral cortex
of 9-day-old BDNF KO−/− animals (Figure 1c, BDNF KO−/−), indicating that the 3C11 antibody is
available for Western blotting of mBDNF and proBDNF. Furthermore, a quantitative analysis indicated
that the percentage of mBDNF to proBDNF in BDNF+/+, BDNFpro/+, and BDNFpro/pro hippocampal
tissues were 92.1 ± 2.8%, 57.7% ± 10.5%, and 6.3% ± 2.5%, respectively (n = 3 independent mice).
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Figure 1. Generation of a knock-in mouse line expressing low levels of mature brain-derived 
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encoding cleavage-resistant proBDNF. (Top) The cleavage-resistant form of BDNF contains two 
amino acid substitutions proximal to the cleavage site of proBDNF. (Bottom) The wild-type allele 
yields an 8.7-kb fragment, and the mutant allele yields a 10.4-kb fragment with XbaI/AatII digestion 
of genomic DNA. XbaI/EheI digestion results in a 6.5-kb fragment in the wild type and a 7.6-kb 
fragment in the mutant. Broken lines in the upper schema indicate the approximate locations of these 
four fragments. (b) Western blot showing the influence of amino acid substitutions (R→M, R→L in 
panel a) proximal to the cleavage site of proBDNF on the expression of proBDNF and mature BDNF. 
Hippocampal lysates (containing 500 µg protein) were incubated with a mouse monoclonal antibody 
(clone; mAb#9) recognizing both proBDNF and mature BDNF [32], and Western blotting was 
performed with a rabbit anti-pan-BDNF monoclonal antibody (clone; EPR1292; Abcam); BDNF+/+, 
BDNFpro/+, BDNFpro/pro mice were 8 weeks old, and BDNF KO+/+ BDNF KO–/– mice were 2 weeks old. 
(c) Immunoblot analysis of mBDNF and proBDNF in hippocampal lysate (25µg protein/lane). 
BDNF+/+, BDNFpro/+, BDNFpro/pro mice were 8 weeks old, and BDNF KO+/+ BDNF KO–/– mice were 9 days 
old. Note that mBDNF and proBDNF were detected with a mouse anti-pan-BDNF monoclonal 
antibody (clone; 3C11, Icosagen), followed by Wosnitzka et al. (2020) [34]. Membranes have been re-
probed with a mouse anti-β-actin monoclonal antibody (clone; AC15, Sigma) to check for an equal 
amount of protein. 
2.2. Body Weight and Heart Morphology 
The proBDNF knock-in gene followed a Mendelian inheritance pattern (Table S1). The 
homozygous mutant mice survived to adulthood, and the body weights of BDNF+/+ and BDNFpro/pro 
littermate mice were comparable (Figure 2a). These results were somewhat unexpected, because Bdnf 
null mice die as a result of severe body size reduction, heart malformation, and intramyocardial 
hemorrhage [35]. However, 7-day-old BDNFpro/pro mice did not exhibit heart malformations or 
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Figure 1. Generation of a knock-in mouse line expressing low levels of mature brain-derived
neurotrophic factor (mBDNF). (a) Strategy used to replace the coding region of Bdnf with cDNA
encoding cleavage-resistant proBDNF. (Top) The cleavage-resistant form of BDNF contains two amino
acid substitutions proximal to the cleavage site of proBDNF. (Bottom) The wild-type allele yields an
8.7-kb fragment, and the mutant allele yields a 10.4-kb fragment with XbaI/AatII digestion of genomic
DNA. XbaI/EheI digestion results in a 6.5-kb fragment in the wild type and a 7.6-kb fragment in the
mutant. Broken lines in the upper schema indicate the approximate locations of these four fragments.
(b) Western blot showing the influence of amino acid substitutions (R→M, R→L in panel a) proximal
to the cleavage site of proBDNF on the expression of proBDNF and mature BDNF. Hippocampal
lysates (containing 500 µg protein) were incubated with a mouse monoclonal antibody (clone; mAb#9)
recognizing both proBDNF and mature BDNF [32], and Western blotting was performed with a rabbit
anti-pan-BDNF monoclonal antibody (clone; EPR1292; Abcam); BDNF+/+, BDNFpro/+, BDNFpro/pro
mice were 8 weeks old, and BDNF KO+/+ BDNF KO−/− mice were 2 weeks old. (c) Immunoblot
analysis of mBDNF and proBDNF in hippocampal lysate (25µg protein/lane). BDNF+/+, BDNFpro/+,
BDNFpro/pr mice were 8 weeks old, and BDNF KO+/+ BDNF KO−/− mice were 9 days old. Note that
mBDNF and proBDNF were detected with a mouse anti-pan-BDNF monoclonal antibody (clone; 3C11,
Icosagen), followed by Wosnitzka et al. (2020) [34]. Membranes have been re-probed with a mouse
anti-β-actin monoclonal antibody (clone; AC15, Sigma) to check for an equal amount of protein.
2.2. Body Weight and Heart Morphology
The proBDNF knock-in gene followed a Mendelian inheritance pattern (Table S1). The homozygous
mutant mice survived to adulthood, and the body weights of BDNF+/+ and BDNFpro/pro littermate mice
were com arable ( igure 2a). These resu ts re somewhat u expected, because Bd f null mice die as a
result of severe body size reduction, heart malformation, and intramyocardial hemorrhage [35].
However, 7-day-old BDNFpro/pro mic did not exhibit heart malformations or intramyocardial
hemorrhages (Figu 2b). An immun histochemical analysis of end thelial marker CD31 indicated
that the endothelial cells in the hearts of ro/pro mice were morp ologically normal (Figure 2c).
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Similarly, immunostaining for phosphorylated TrkB indicated normal activation of this receptor
(Figure 2d). Together, these results suggest that inefficient cleavage of proBDNF to mBDNF does not
influence animal survival or heart morphology.
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Figure 2. Body weights and heart morphology. (a) Mean body weights of 10-week-old BDNF+/+ and
BDNFpro/pro animals. Error bars represent SEMs from 8 mice/group. (b) Hematoxylin and eosin-stained
heart sections of 7-day-old mice with the indicated genotypes. The staining was performed as described
by Donovan et al. [35]. Abbreviations: ra, right atrium; la, left atrium; rv, right ventricle; lv, left ventricle.
(c,d) Immunostaining of BDNF+/+ and BDNFpro/pro heart sections using an antibody against CD31 (c)
or phosphorylated TrkB. (d) Scale bars, 1 mm (b) and 50 mm (c,d).
2.3. Impact of Social Isolation on Depressive-Like Behavior of BDNFpro/+ Mice
To study if the conversion of proBDNF into mBDNF is associated with the development of
depressive-like be aviors, we reared 6-week-old male BDNFpro/+ heterozygous mice, in which BDNF
levels were reduc d to 57.7% ± 10.5% of that in BDNF+/+ mice (n = 3 independent i ), and t eir
age-matched wild-type litt rmates under conditions of social isolation or group housing for 8 weeks
(Figure 3a) ccor ing to a previous report [36]. To assess depressive-like behavi rs, we measured
immobility times in the tail suspension test, which is thought to measure despair under extrem
adversity [37]. The BDNFpro/+ mice reared in ocial i olation exhibited approximately 2-fold lo g
immobility times than group-housed BDNFpro/+ animals (Figure 3b; p < 0.05, ANOVA followe
by Tukey–Kramer test). By contrast, ther was no difference in immobility between BDNF+/+ mice
housed in groups or in social isolation (Figure 3b). Furthermore, BDNFpro/+ mic housed in social
is lation for 8 weeks showed significantly increased food intake and body weights compared to those
h used in groups. Social isolation did not induce increases in weight or food intake in wild-typ
mice (Figure 3c,d; p < 0.001, one-way ANOVA follow d by Tukey–Kramer test). These results suggest
that impaired cleavage of proBD F into mBDNF promotes depressive-like behaviors, observed s
increase mobility in the tail suspe sion test and increased food intake and body weight in socially
isolated BDNFpro/+ mice.
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Figure 3. Behavioral phenotypes of BDNFpro/+ mice housed for 8 weeks in social isolation. (a) Housing
conditions. Three mice were housed in each cage for group housing, whereas one mouse was housed
in each social isolation cage (according to Wallace et al. [36] with some modification). (b) After 8 weeks,
mice housed in group or social isolation cages were subjected to the tail suspension test, as described
in Materials and Methods. (c) Food intake was measured every day for 8 weeks, and the mean daily
amount of food intake was determined. (d) Body weights were measured after the tail suspension
test. Data are presented as means ± SEMs from 10–12 animals/group. * p < 0.05, ** p < 0.001, one-way
ANOVA followed by Tukey–Kramer test.
2.4. Impaired Nest Building in Socially Isolated BDNFpro/+ Mice
The construction of a nest is a deliberate behavior performed by mice to improve fitness and
survival. To see if altered BDNF levels influence this behavior, we first housed BDNFpro/+ and
BDNF+/+ mice for 8 weeks under social isolation or group-housed conditions and then scored their
12 h nest-building behavior according to the protocol described by Deacon [38,39]. BDNF+/+ mice
showed interest in nest materials, shredding the materials and completing their nests within 3–4 h
(Figure 4a). However, socially isolated BDNFpro/+ mice exhibited significantly poorer nest building
than group-housed BDNF+/+ and BDNFpro/+ mice (Figure 4b; p < 0.001, one-way ANOVA followed
by Tukey–Kramer test). These results suggest that deficient proBDNF cleavage influences a normal
survival behavior.
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Figure 4. Deficit in nest building by socially isolated BDNFpro/+ mice. (a) Nest-building scoring (from
1 to 5, as described in Materials and Methods). (b) BDNFpro/+ and BDNF+/+ mice were housed in
group or social isolation cages for 8 weeks before they were subjected to the nest-building behavioral
test. Data are presented as the means ± SEMs from ten animals/group (** p < 0.001, one-way ANOVA
followed by Tukey–Kramer test).
3. Discussion
The in vivo roles of mBDNF and related molecules in depression have been extensively explored
in genetically engineered mouse lines [40]. To investigate this in a more pathophysiologically relevant
context, we focused on Bdnf alleles with a sequence containing two rare human SNPs proximal to the
cleavage site of proBDNF. A bioinformatic analysis performed previously [29] indicated that these
SNPs would interrupt proteolytic cleavage. In the present study, we generated knock-in mice in
which the gene encoding Bdnf was replaced with a sequence for proBDNF containing human single
nucleotide polymorphisms encoding arginines proximal to the cleavage site (R125M and R127L) and
demonstrated that these mutations in the Bdnf gene lead to a gene dosage-dependent decrease in the
levels of mBDNF as a result of inefficient cleavage of proBDNF.
Second, we showed that the homozygous mice survived until adulthood, unlike Bdnf null
mice that die at an early postnatal age as a result of severe heart malformation and intramyocardial
hemorrhage [35]. However, no such defects were observed in BDNFpro/pro mice. This may be explained
by the residual levels of mBDNF observed in our homozygous mice. Yang et al. generated a knock-in
mouse line with mutations at the second and third arginines (rather than the first and second), which
completely inhibited proBDNF cleavage [41]. These two studies using knock-in mice with distinct
mutations suggest that the three arginine residues located near the cleavage site of proBDNF play
different roles in the proteolytic cleavage of proBDNF.
To verify that mutations (R→M, R→ L, Figure 1a) impair proBDNF cleavage, we examined the
expression of mBDNF and proBDNF. As BDNF proteins were not abundant in the hippoca pal lysates,
IP-WB was performed according to the method described by Rauskolb et al. (2010) [32]. The experiments
showed that mBDNF is expressed at a higher level than proBDNF wild-type animals (Figure 1b), in line
with the notion that proBDNF is rapidly converted into mBDNF mainly in naïve neurons [42]. Further,
we confirmed the presence of proBDNF in wild-type mice via immunoprecipitation with a mouse
monoclonal antibody recognizing the BDNF pro-domain (3C10H), which recognizes proBDNF but not
BDNF, followed by Western blotting with a rabbit anti-pan-BDNF monoclonal antibody (EPR1292)
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(Figure S1, BDNF KO+/+); the lysates prepared from BDNF KO-/- mice did not contain proBDNF.
Furthermore, Western blot analysis was performed to examine the ratio of mBDNF to proBDNF
using a monoclonal anti-BDNF antibody (clone; 3C11, Icosagen). Until now, the confusing results
of biochemistry would have arisen from the use of unsuitable antibodies. However, Wosnitzka et al.
(2020) showed that BDNF antibody 3C11 detected both mBDNF and pro-BDNF with transfected
cells and that these bands were not seen in Western blot when used with lysates prepared from
Bdnf−/− animals [34]. Using the mouse anti-pan-BDNF monoclonal antibody 3C11, percentage of
mBDNF to proBDNF in BDNF+/+, BDNFpro/+, and BDNFpro/pro in mice was 92.1 ± 2.8%, 57.7% ± 10.5%,
and 6.3% ± 2.5%, respectively. These findings indicate that the ratio of mBDNF to proBDNF depends
on the number of copies of the mutant gene.
The neurotrophic hypothesis of depression states that a deficiency in neurotrophic support
contributes to the development of depression, and most related studies have focused on the neurotrophin
mBDNF [40]. However, reductions in mBDNF levels or TrkB signaling are not solely responsible for
depressive-like behaviors, because mice lacking one allele of Bdnf resulting in a 50% reduction in
mBDNF levels do not exhibit depressive-related behaviors, whereas female mice with specific loss of
mBDNF expression in forebrain exhibited depressive-like behaviors [16]. Given that another study
showed that knockdown of BDNF in the dentate gyrus induces depression-like effects in rats [17],
the role of BDNF in depression needs further investigation at molecular cellular levels.
In the present study, we demonstrated that mBDNF levels in the hippocampus are reduced
by approximately 57% in BDNFpro/+ heterozygous mice and that these mice exhibit depressive-like
behaviors after being housed in social isolation. As BDNFpro/+ mutant mice exhibited reduced mBDNF
levels as a result of inefficient cleavage of proBDNF and spent more time immobile in the tail suspension
test after being housed in social isolation, the stress of social isolation and impaired proBDNF cleavage
may cooperatively promote depressive-like behavior. In line with these findings, it was reported that
the ratio of mBDNF to proBDNF increases in mice subjected to chronic unpredicted mild stress that
exhibit depressive-like behaviors [43] as well as in a rat model of anxiety induced by intraplantar
injections of complete Freund’s adjuvant and a model of depression induced by chronic restraint
stress [44]. Moreover, a clinical report indicated that the mBDNF/proBDNF ratio in serum is a potential
biomarker to discriminate patients with bipolar depression among those with depressive episodes [45].
Stress, a risk factor for depression [46], influences the function of mBDNF and synapse
in brain [47,48]. It was demonstrated that mice exposed to social stress exhibited BDNF
downregulation [22]. Notably, Hajszan et al. performed quantitative electron microscopic stereology
and demonstrated that depression, stress, and corticosterone administration lead to hippocampal
spine synapse loss and shrinkage of pyramidal cell dendritic trees [49]. Our in vitro study showed that
the impairment of proBDNF cleavage resulted in the shrinkage of the morphology of hippocampal
dendritic spines in culture [29]. Thus, it would be interesting to examine in the future whether proBDNF
cleavage, a posttranslational mechanism of mBDNF production, contributes to such remodeling of
spine synapses with stress and depression.
Most research of depression has focused on the hippocampus and frontal cortex. However,
these limbic regions interconnect with subcortical structures that contribute to various symptoms of
depression [26], such as food intake and body weight. Indeed, mBDNF is highly expressed in the
hypothalamus as well as the hippocampus [31]. Recently, it was demonstrated that signaling through
TrkB in the hypothalamus was crucial for controlling satiety and body weight (reviewed by Xu and Xie
(2016) [50]). In the present study, BDNFpro/+ mice housed in social isolation increased their food intake
and body weights. Thus, taken together, singly housed BDNFpro/+ mice, which exhibit increased food
intake and body weights, may have impaired hypothalamic mBDNF signaling.
Interestingly, it was previously reported that Bdnf gene expression in the hypothalamus induced by
environmental enrichment induces the browning of white adipocytes [51]. However, Bdnf expression
was not different between BDNFpro/+ and BDNF+/+ mice housed in social isolation (Figure S2).
We further found that the total amount of BDNF-immunoreactive protein (Mbdnf + proBDNF) was not
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different between the genotypes (1 ± 0.07 [BDNF+/+] versus 1.16 ± 0.10 [BDNFpro/+]; p = 0.30 by t test,
n = 3 mice). Therefore, since the percentage of mBDNF to proBDNF was lower in BDNFpro/+ mice than
that of BDNF+/+ animals (Figure 1b,c), the observed increases in weight or food intake in BDNFpro/+
animals might be attributable to the reduction of mBDNF levels. However, in hypothalamus, BDNF
expresses in some neural circuits [50]. To understand the pathophysiological influence of impaired
processing of proBDNF in the hypothalamic function, we will study the ratio of mBDNF to proBDNF
using the tissues including BDNF-expressing neural circuits in BDNFpro/+ hypothalamus in the future.
A surprising finding in the present study is that BDNFpro/+ mice housed alone show an impairment
in nest-building behavior. These data suggest that mBDNF plays an important role in this natural daily
behavior. Nest building is an innate but complex goal-directed behavior [52,53] that requires neural
processes in the frontal cortex and hippocampus [54–58], two brain regions that express mBDNF [31].
Thus, reduced levels of mBDNF may impair complex goal-directed and natural daily behaviors.
Nevertheless, we cannot rule out the contribution of decreased concentration on task completion
or impaired motivation, both of which are cardinal signs of major depressive disorder, because the
BDNFpro/+ mice housed alone exhibited depressive-like behaviors. We recently reported a pronounced
impairment of nesting behavior in socially defeated mice [59]. This nesting deficit was partially rescued
by the serotonin 2A (5-HT2A) receptor antagonist [60], which was also found to block the stress-induced
downregulation of Bdnf mRNA expression in hippocampus [61]. Furthermore, an increase in the
5-HT2A receptor in the hippocampus has also been observed in depressed patients [62]. Given these
findings, mBDNF and serotonin signaling might contribute to the performance of daily behaviors,
which should be explored in more detail in the future.
4. Materials and Methods
4.1. Animals, Breeding Procedures, Housing Conditions, and Animal Ages at Each Experiment
All animal experiments were performed in strict accordance with protocols that were approved by
the Institutional Animal Care and Use Committee of AIST. All efforts were made to minimize animal
suffering during the experiments (number.2019-084, approval date 6 June 2015). Wild-type mice with
the background of C57BL/6J were obtained from Crea Japan (Shizuoka, Japan). Mice were housed with
access to regular laboratory chow (MF; Oriental Mouse Food, Tokyo, Japan) and water ad libitum at
constant room temperature (24 ± 2 ◦C) and were exposed to a 12 h light/dark cycle (lights on from 7 a.m.
to 7 p.m.). All mice were housed in groups of three per cage prior to the experiments. Social isolation
paradigm is according to the report by Wallace et al. [36] with some modification. For the 8 weeks of
social isolation, mice were moved to individual cages at 6 weeks of age. The approximate ages of the
mice when each experiment was performed are as follows: immunoblotting and immunocytochemistry,
8 weeks old; measurement of body weight, 10 weeks old; hematoxylin and eosin staining, 7 days old;
behavioral tests, 14 weeks old.
4.2. Generation of the proBDNF Knock-in Mouse Line
The proBDNF knock-in mouse line was generated by replacing the endogenous Bdnf allele
with cDNA encoding two mutations proximal to the cleavage site of proBDNF (RVRR to MVLR),
resulting in a cleavage-resistant form of BDNF using the methods described by Inoue et al. [30].
Briefly, a 6.0-kb long-arm fragment (NCBI accession number: AY057907, 49015–54460) and a 3.4-kb
short-arm fragment (55207–58754) flanking the 5′ and 3′ ends, respectively, of mouse Bdnf exon 5
were PCR amplified from 129SV mouse genomic DNA. These fragments were introduced into the
ClaI-NotI and PacI-AscI sites, respectively, of the pMulti-ND 1.0 vector. A DNA fragment encoding
mutant proBDNF was then inserted into the ClaI-NotI site of the targeting vector. A pGK-thymidine
kinase gene was used as a negative selectable marker in the vector (see Figure 1a). The linearized
targeting vector was electroporated into embryonic stem (ES) cells of the D3 line (strain 129SV).
DNA derived from G418-resistant ES clones was screened by PCR, and positive ES clones were injected
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into blastocysts obtained from C57BL/6J mice. The injected blastocysts were then introduced into
the uteri of pseudopregnant females. Chimeric mice were mated with C57BL/6J mice to produce
heterozygotes, and these mice were subsequently crossed with mice expressing Cre recombinase in
germ cells to excise the neo cassette [30]. Genetic backcrosses to the C57BL/6J and 129SV backgrounds
were performed for at least ten generations before the animals were used in behavioral analyses and in
all other analyses, respectively. Thus, proBDNF knock-in mice have a C57BL/6J genetic background.
4.3. Genotyping
Genotyping of the proBDNF knock-in mouse line was performed using the following
primers: 5′-TGCACCACCAACTGCTTAG-3′ and 5′-GGATGCAGGGATGATGTTC-3′. PCR analyses
using these primers generated 550-bp and 320-bp DNA fragments from wild-type and mutant
alleles, respectively. Genotyping of the BDNF knock-out mice was performed using the
following primers: 5′-ATGAAAGAAGTAAACGTCCAC-3′, 5′-CCAGCAGAAAGAGTAGAGGAG-3′,
and 5′-GGGAACTTCCTGACTAGGGG-3′. PCR analyses using these primers generated 275-bp and
340-bp DNA fragments from wild-type and mutant alleles, respectively.
4.4. Generation of Anti-proBDNF Antibody
A peptide with the sequence KVRPNEENNKDADLY (aa 76–90) [33] was synthesized via a
fluorenyl methoxy carbonyl-based liquid-phase peptide synthesis process. The peptide was conjugated
with keyhole limpet hemocyanin, emulsified with Freund’s adjuvant (Pierce, Rockford, IL, USA),
and then used to immunize female mice to screen hybridoma clones. Clone 3C10H was selected
from the initial screening and further characterized using hippocampal lysates from BDNF KO and
wild-type littermates as shown in Figure S1.
4.5. Immunoprecipitation and Immunoblot Analysis
A purified mouse monoclonal antibody recognizing BDNF and proBDNF (clone; mAb#9) was
generously provided by Professor Yves-Alain Barde (School of Biosciences, Cardiff University, United
Kingdom). First, hippocampi were dissected from 9- or 2-week-old mice of the designated genotypes,
weighed, and stored at −80 ◦C. The dissected hippocampi were lysed in RIPA buffer (Thermo Scientific,
Waltham, MA, USA) containing a protease inhibitor mixture (Roche Diagnostics, Basel, Switzerland)
using a sonicator (TAITEC, Saitama, Japan), and the supernatants of the lysates were collected after
centrifugation at 20,400× g for 10 min. The protein concentration of the supernatants was determined
using a BCA assay kit (Thermo Scientific). The supernatants containing 500 µg of total protein were
incubated with the BDNF monoclonal antibody (mAb#9) or proBDNF monoclonal antibody (3C10H) at
4 ◦C for 24 h and subsequently incubated with protein G Sepharose beads (GE Healthcare Life Sciences,
Piscataway, NJ, USA) at 4 ◦C for 2 h. Precipitates were collected by centrifugation, eluted with sample
buffer, and stored at −80 ◦C.
The precipitates were boiled for 5 min at 100 ◦C, electrophoresed on 20% SDS-polyacrylamide
gels, and then transferred to polyvinylidene fluoride membranes using the Trans-Blot Turbo transfer
system (Bio-Rad, Hercules, CA, USA). The membranes were blocked in Tris-buffered saline containing
0.2% Tween-20 (TBST) and 5% non-fat dry milk (WAKO, Osaka, Japan), incubated with a rabbit
anti-pan-BDNF monoclonal antibody (clone; EPR1292; Abcam, Cambridge, MA, USA) in TBST
containing 3% BSA at 4 ◦C overnight, and then washed three times with TBST. Subsequently,
the membranes were incubated at room temperature for 1 h with peroxidase-conjugated secondary
antibodies (GE Healthcare Life Sciences) in TBST containing 3% BSA and washed three times with
TBST. The signal was detected using Luminata Forte HRP Substrate (Merck Millipore, Billerica, MA,
USA). The blot images were captured with Image Quant Las 500 imager (GE Healthcare Life Science),
and the exposure time was adjusted such that the intensity of the bands was within the linear range.
Quantification of the intensity of BDNF bands was demonstrated using Image Quant TL software
(GE Healthcare Life Science). As a control, E. coli-derived proBDNF [29] and mBDNF were loaded
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(Figure 1b and Figure S1). E. coli-derived mBDNF was kindly provided by Sumitomo Pharmaceuticals
(Osaka, Japan).
For Western blot study (Figure 1c), hippocampal lysates (25 µg) were resolved on 20% SDS-PAGE
and then transferred onto PVDF membranes. After that membrane was incubated with a mouse
anti-pan-BDNF antibody (clone; 3C11, Icosagen, Estonia). A monoclonal β-actin antibody (clone;
AC15, Sigma, USA) was used as a loading control.
4.6. Heart Morphology
Heart malformation and intramyocardial hemorrhage were investigated according to a previous
report [35].
4.7. Immunohistochemistry
A purified anti-phospho-TrkB antiserum was generously provided by Professor Moses Chao
(Skirball Institute of Biomolecular Medicine, New York University Langone Medical Center, New York,
NY, USA). For immunohistochemistry, 10-week-old mice were anesthetized and transcardially perfused
with phosphate-buffered saline (PBS) followed by 4% paraformaldehyde in PBS. The brains were
postfixed overnight at 4 ◦C, cryoprotected, and then cut into 30 µm sections.
Immuno-staining using a rat monoclonal anti-mouse CD31 antibody (1:100, clone MEC 13.3;
BD Pharmingen, San Jose, CA, USA) was performed to identify endothelial cells in the mouse heart.
Briefly, the sections were treated with 0.1% hydrogen peroxide and then incubated with the primary
CD31 antibody. To detect the activated TrkB receptor, the purified anti-phospho-TrkB antiserum
was used. Signal amplification was performed using the avidin/biotinylated horseradish peroxidase
complex method (Vectastain ABC; Vector Labs, Burlingame, CA, USA). Light microscopy images were
obtained using Eclipse E600 Microscope (Nikon, Tokyo, Japan) and a 20× Plan Apo, 0.75 numerical
aperture lens objective (Nikon).
4.8. Body Weight and Food Intake
The body weights of mice were measured after the tail suspension test. The daily amount of food
intake was determined on a per-cage basis from the actual amount of food consumed.
4.9. Tail Suspension Test
After 8 weeks of group housing or social isolation, the tail suspension test was performed on
an automated tail suspension device (Muromachi Kikai, Tokyo, Japan). According to a previous
report [37], animals were suspended from a strain gauge for 6 min. Time spent immobile was recorded
in seconds. The settings for the equipment were as follows: time constant = 0.25, gain = 4, threshold 1
= 3, and resolution = 200 ms.
4.10. Nest-Building Assessment
Nest-building behavior was assessed after 8 weeks of group housing or social isolation by using
a standardized scoring scale described in a previous report [38]. Initially, one piece of nest material
(Nestlet, ~3 g; Animec, Japan) was placed on the floor in the center of the home cage (220 × 320 ×
135 mm) at 8:00 pm. The nests were assessed 12 h later according to a 5-point scale (see Figure 4a and
BOX 1 in the article by Deacon [38]).
4.11. Statistics
All the data are presented as means ± standard errors of the means (SEMs). For statistical analyses,
Student’s t tests (Figure 2a and Figure S2) and one-way ANOVAs followed by Tukey–Kramer’s
multiple-comparison tests (Figures 3 and 4) were used. A p value of <0.05 was considered significant.
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Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/21/11/
3984/s1. Table S1. The frequencies were determined on the basis of genotyping of 63 pups from six independent
colonies. Figure S1. Western blotting was performing using hippocampal lysates prepared from 8-week-old
BDNFpro/pro mice and 10-day-old BDNF KO−/− and BDNF KO+/+ animals. Figure S2. Quantitative real-time PCR
analysis. The levels of Bdnf mRNA in the hippocampi prepared from BDNFpro/+ and BDNF+/+ mice (8 weeks old)
were measured.
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